Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Natalben Supra is a comprehensive nutritional supplement developed and marketed by Laboratorios Mallén, specifically formulated to support the nutritional requirements of women throughout pregnancy. It is a multi-ingredient food supplement rather than a traditional pharmaceutical drug, containing a combination of essential vitamins, minerals, and omega-3 fatty acids. Key active ingredients include folic acid (vitamin B9), vitamin B12, vitamin D, iodine, and iron, alongside docosahexaenoic acid (DHA) derived from fish oil. The product is indicated for use during pregnancy to support maternal health and promote healthy fetal development, contributing to the prevention of neural tube defects, supporting cell division, and aiding in the baby's cognitive, brain, and visual development. It is available in soft capsule form and is marketed in various Latin American countries, including the Dominican Republic and Peru.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Natalben Supra.